A new study suggesting that nitrofurantoin and sulfonamides are teratogenic highlights the need for a risk-benefit analysis when your patient is a woman of reproductive age.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3183938 | PMC |
Publication Analysis
Top Keywords
treating utis
4
utis reproductive-age
4
reproductive-age women-proceed
4
women-proceed caution
4
caution study
4
study suggesting
4
suggesting nitrofurantoin
4
nitrofurantoin sulfonamides
4
sulfonamides teratogenic
4
teratogenic highlights
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!